In a large real-world analysis across three U.S. healthcare databases, semaglutide and tirzepatide showed cardiovascular benefits consistent with randomized trials. Semaglutide lowered heart attack ...

Injectable weight-loss drugs can reduce the risk of serious cardiovascular events for people with type 2 diabetes.

The authors said: “T2D remission is not rare after initiation GLP-1RA, its frequency and duration varying by definition. When ...

Determining the type of diabetes a patient has at diagnosis can be challenging, and health care professionals should focus on each patient’s clinical condition when determining initial treatment, ...

People with type 2 diabetes who combined healthy lifestyle habits with GLP-1 receptor agonist (GLP-1 RA) medications had a ...

Adult and pediatric experts from @HopkinsMedicine, @EndoHopkins, and @HopkinsKids are available all month to raise diabetes awareness and discuss how the disease impacts adults and children.

Type 2 diabetes (T2D) is a chronic metabolic disorder characterised by insulin resistance and impaired insulin secretion, ...

Diabetes is so common that you’d be hard pressed not to have a family member or close friend who’s living with it. Thankfully ...

In this conversation, Elizabeth Dabrowski, M.D., pediatric endocrinologist at Children's Wisconsin, and Matthew Edwards, R.D., diabetes care and education specialist at Children's Wisconsin Diabetes ...

The results of a late-stage drug trial released Thursday are raising hopes that type 1 diabetes patients with chronic kidney ...

The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a new study finds, even though there’s little information on the drugs’ safety ...